Merck board declares $0.85 common stock dividend for Q3 2026

Merck (NYSE:MRK) announced that its board of directors has formally declared a quarterly dividend of $0.85 per share.

The Rahway, New Jersey-based pharmaceutical company—which operates under the trade name MSD outside of the United States and Canada—stated that the dividend distribution will be executed on July 8, 2026.

Institutional and retail investors holding the equity at the close of business on the record date of June 15, 2026, will be eligible for the cash payout.

The dividend declaration matches the payout rate established in previous consecutive quarters, reflecting management's ongoing commitment to its balanced capital allocation strategy.

The recurring distribution draws from the drugmaker’s established commercial portfolio, anchored by key oncology treatments, vaccines, and animal health products, which continue to generate steady cash flows.